Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07412743

Multilevel Peer-to-Peer HPV Vaccination and Wellness Educational Program in School Based Health Centers

School-based health centers (SBHCs) are an important setting to improve health through detecting, managing and preventing chronic illness. Too few people are educated about the human papillomavirus (HPV), which can prevent tens of thousands of deaths from cancer each year. PEER will evaluate a program to increase health and wellness and the use of SBHCs for primary and preventive care. If successful, PEER could significantly increase the use of SBHCs, and decrease HPV-associated cancers and, thus, reduce the burden of cancer in the United States.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

School Health Services

Age range

9 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kaiser Permanente Center for Health Research

Portland, Oregon, 97227, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 9-18
  • New or established patients
  • Flagged if due for an HPV vaccine

Exclusion criteria

  • None

Treatment and study plan

Mailers

Behavioral

Letter and fact sheet (infographic) mailed to caregivers of 9-14 year-olds and to teens 15-18, with optional phone call for "confidential patients" aged 15-18.

Provider Materials

Behavioral

Clinic team/staff training based on qualitative interviews, recommended strategies and evidence-based interventions. Training materials include FAQs and Smart phrases. FAQs and informational sheets containing the same content as the mailers distributed in clinic to teen SBHC patients and their caregivers.

Peer-to-Peer Educational Sessions

Behavioral

Educational sessions delivered in schools by OSBHA interns. Session content includes SBHC information and HPV awareness.

Primary outcomes

  1. Rate of Vaccination for HPV (n of patients with HPV vaccination/n of patients eligible for vaccination)

    Time frame: 6 and 12 months

    Vaccination among eligible clinic patients, and time to vaccination

Secondary outcomes

  1. Rates of new patients to the clinic (n of new patients/n of established patients)

    Time frame: 6 and 12 months

    New patients seen (vs. prior seen pts.) - New patient characteristics (age, rural)

  2. Rate of use of other SBHC services (primary care visits, wellness assessments) (n of patients with primary care visits/n of new and established patients)

    Time frame: 6 and 12 months

    Use of other SBHC services and visits among eligible clinic patients

  3. Rate of vaccination for other adolescent vaccinations (COVID-19, flu, Meningitis, or uptick of other vax's (TDAP, MMR, etc.)) (n of patients with additional vaccination among new and eligible clinic patients)

    Time frame: 6 and 12 months

    Vaccination among eligible clinic patients, and time to vaccination

Sponsors and collaborators

Lead sponsor

Kaiser Permanente

Other

Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

Registry information

Acronym: PEER

Important dates

Study start
2026
Primary completion
2028
Study completion
2029
First posted
Feb 17, 2026
Registry last updated
May 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.